ConductScience.org, home

Paper41008883

Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial.

Callaghan JP and 11 others. Cancers (Basel), 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial. Papers, record 41008883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-09-30
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Callaghan JPJonathan Phttps://orcid.org/0000-0001-7506-906X
2Jarrett RRosshttps://orcid.org/0000-0002-4867-0981
3Westwood ACAlice Chttps://orcid.org/0000-0002-8697-9621
4Laye JJon
5Quirke PPhiliphttps://orcid.org/0000-0002-3597-5444
6Magee DRDerek Rhttps://orcid.org/0000-0003-2170-3103
7Bottomley DDaniel
8Sebag-Montefiore DDavid
9Thompson LLindsayhttps://orcid.org/0000-0003-2651-4512
10Meade AAngela
11Grabsch HIHeike I
12West NPNicholas Phttps://orcid.org/0000-0002-0346-6709

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RRCOER-Jun24/100004Cancer Research UKUnited KingdomPubMed
NIHR203331National Institute for Health ResearchPubMed

Source PubMed

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133223535The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.Br J Cancer2021https://conductscience.org/library/papers/33223535PubMed
230284239Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30284239PubMed
331869737The local inflammatory response in colorectal cancer - Type, location or density? A systematic review and meta-analysis.Cancer Treat Rev2020https://conductscience.org/library/papers/31869737PubMed
437345012Tumor-Stroma Ratio in Colorectal Cancer-Comparison between Human Estimation and Automated Assessment.Cancers (Basel)2023https://conductscience.org/library/papers/37345012PubMed
530116024A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.Br J Cancer2018https://conductscience.org/library/papers/30116024PubMed
633008040Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response.Cancers (Basel)2020https://conductscience.org/library/papers/33008040PubMed
736403589
Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision.
Lancet Healthy Longev2022https://conductscience.org/library/papers/36403589PubMed
840293274Prognostic Value of CD8+ T Cells at the Invasive Margin Is Comparable to the Immune Score in Nonmetastatic Colorectal Cancer: A Prospective Multicentric Cohort Study.Clin Cancer Res2025https://conductscience.org/library/papers/40293274PubMed
919269519Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.Lancet2009https://conductscience.org/library/papers/19269519PubMed
1036238289The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients.Front Immunol2022https://conductscience.org/library/papers/36238289PubMed
1133678606Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.J Immunother Cancer2021https://conductscience.org/library/papers/33678606PubMed
1234868930Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review.Front Oncol2021https://conductscience.org/library/papers/34868930PubMed
1334533595Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.Int J Colorectal Dis2021https://conductscience.org/library/papers/34533595PubMed
1432099066The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.Sci Rep2020https://conductscience.org/library/papers/32099066PubMed
1531543678Neoadjuvant radiotherapy for rectal cancer management.World J Gastroenterol2019https://conductscience.org/library/papers/31543678PubMed
1630559429U-Net: deep learning for cell counting, detection, and morphometry.Nat Methods2019https://conductscience.org/library/papers/30559429PubMed
1739948076Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.Sci Rep2025https://conductscience.org/library/papers/39948076PubMed
1838572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1934123856Prognostic Value of Tumor-Stroma Ratio in Rectal Cancer: A Systematic Review and Meta-analysis.Front Oncol2021https://conductscience.org/library/papers/34123856PubMed
2040033106Deep-learning enabled combined measurement of tumour cell density and tumour infiltrating lymphocyte density as a prognostic biomarker in colorectal cancer.BJC Rep2025https://conductscience.org/library/papers/40033106PubMed

See all 37 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42449690Lactate Dehydrogenase-5 and Tumor-Infiltrating Lymphocytes in Prostate Cancer Patients Undergoing Radical Hypofractionated Radiotherapy.Cancers (Basel)2026https://conductscience.org/library/papers/42449690PubMed
42449633Tumour-Stroma Ratio as a Predictive Biomarker for Neoadjuvant Therapy Efficacy in Rectal Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42449633PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41008883

GET https://conductscience.org/api/papers/v1/41008883/references?page=2